scorecardresearch
Add as a preferred source on Google
Saturday, April 11, 2026
TopicPharmacy of the world

Topic: Pharmacy of the world

India inspects drug factories as Gambia controversy lingers

The deaths of at least 70 children in Gambia has dented the pharmaceutical industry's image, though India says the drugs made by New Delhi-based Maiden Pharmaceuticals Ltd were not at fault.

Modi govt refreshes plan to prioritise drug discovery, will launch hunt for ‘R&D head’

Modi govt’s efforts seek to address criticism lobbed at India for failing to discover even a single drug molecule despite being the largest producer of generic medicines in the world.

Indian vaccine exports take ill as they are not immune to Chinese competition bug

Indian vaccine exports have been falling steadily since 2015-16 even as the global market has been expanding under the threat of new pandemics.

On Camera

What can be expected from the ongoing talks in Islamabad? Odds of resolution remain slim

The initial ceasefire functioned less as a resolution and more as a pause—an opportunity for both sides to recalibrate, while claiming victory.

India bond yields rise as RBI moves to drain liquidity, lift overnight rates

New Delhi: India’s sovereign bond yields rose after the central bank announced its first step this year to drain cash from the banking system,...

Army promotes Col Purohit, acquitted in 2008 Malegaon blast case, to Brigadier; to not retire yet

This means he will serve Indian Army for a minimum of another 2 years as Brigadier, unless he picks up the next rank of Major General.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.